GlassScriptPhysician profile
Noel Torres
NPI 1003494964
$3,121.91
in general payments reported to CMS, 2019-2025
19 companies · $2,130 in 2025
The $2,130 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $992 · 2025: $2,130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,121.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $368.06 | 2024-2025 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $367.14 | 2024-2025 | |
| Dexcom, INC. | $320.66 | 2024-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Amgen INC. | $310.41 | 2024-2025 | Evenity, Tepezza, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $202.31 | 2024-2025 | Jardiance |
| Bayer Puerto Rico INC. | $164.86 | 2024-2025 | Kerendia |
| Radius Health, INC. | $158.20 | 2025 | Tymlos |
| Novo Nordisk INC | $157.24 | 2024-2025 | Ozempic, Rybelsus |
| Eli Lilly Export S.A. Puerto Rico Branch | $154.54 | 2024-2025 | Mounjaro |
| Rhythm Pharmaceuticals, INC. | $151.79 | 2025 | Imcivree |
| Abbott Laboratories | $135.37 | 2024-2025 | Freestyle Libre 3 |
| Medtronic, INC. | $131.88 | 2025 | Simplera Sensor |
| Kyowa Kirin, INC. | $118.71 | 2024 | Crysvita |
| Lilly USA, LLC | $117.87 | 2025 | Zepbound |
| Novartis Pharmaceuticals Corporation | $87.88 | 2024-2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Perspectum Diagnostics LTD | $72.70 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $57.29 | 2024-2025 | Lokelma |
| E.R. Squibb & Sons, L.L.C. | $25.00 | 2024 | Eliquis |
| Verity Pharmaceuticals INC. | $20.00 | 2025 | Trelstar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noel Torres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.